Astrana Health Inc. (ASTH)
NASDAQ:ASTH
Want to see ASTH full AI Analyst Report?
Total Valuation
Astrana Health has a market cap or net worth of $1.76B. The enterprise value is $2.48B.
Market Cap$1.76B
Enterprise Value$2.48B
Share Statistics
Astrana Health has 45,020,462 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding45,020,462
Owned by Insiders36.13%
Owned by Institutions4.85%
Financial Efficiency
Astrana Health’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 2.88%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)2.88%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee1.67M
Profits Per Employee12.67K
Employee Count1,900
Asset Turnover1.43
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Astrana Health is 20.7. Astrana Health’s PEG ratio is -1.09.
PE Ratio20.7
PS Ratio0.38
PB Ratio1.56
Price to Fair Value1.56
Price to FCF11.65
Price to Operating Cash Flow11.26
PEG Ratio-1.09
Income Statement
In the last 12 months, Astrana Health had revenue of 3.18B and earned 22.49M in profits. Earnings per share was 0.46.
Revenue3.18B
Gross Profit295.78M
Operating Income78.53M
Pretax Income39.61M
Net Income22.49M
EBITDA124.27M
Earnings Per Share (EPS)0.46
Cash Flow
In the last 12 months, operating cash flow was 166.03M and capital expenditures -11.04M, giving a free cash flow of 154.99M billion.
Operating Cash Flow166.03M
Free Cash Flow154.99M
Free Cash Flow per Share3.44
Dividends & Yields
Astrana Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.12
52-Week Price Change44.08%
50-Day Moving Average23.78
200-Day Moving Average25.94
Relative Strength Index (RSI)78.79
Average Volume (3m)400.00K
Important Dates
Astrana Health upcoming earnings date is Aug 12, 2026, TBA (Confirmed).
Last Earnings DateMay 7, 2026
Next Earnings DateAug 12, 2026
Ex-Dividend Date―
Financial Position
Astrana Health as a current ratio of 1.40, with Debt / Equity ratio of 133.10%
Current Ratio1.40
Quick Ratio1.40
Debt to Market Cap0.86
Net Debt to EBITDA5.22
Interest Coverage Ratio1.57
Taxes
In the past 12 months, Astrana Health has paid 15.53M in taxes.
Income Tax15.53M
Effective Tax Rate0.39
Enterprise Valuation
Astrana Health EV to EBITDA ratio is 15.02, with an EV/FCF ratio of 17.86.
EV to Sales0.59
EV to EBITDA15.02
EV to Free Cash Flow17.86
EV to Operating Cash Flow16.29
Balance Sheet
Astrana Health has $478.38M in cash and marketable securities with $1.07B in debt, giving a net cash position of -$586.81M billion.
Cash & Marketable Securities$478.38M
Total Debt$1.07B
Net Cash-$586.81M
Net Cash Per Share-$13.03
Tangible Book Value Per Share-$11.75
Margins
Gross margin is 9.31%, with operating margin of 2.47%, and net profit margin of 0.71%.
Gross Margin9.31%
Operating Margin2.47%
Pretax Margin1.24%
Net Profit Margin0.71%
EBITDA Margin3.91%
EBIT Margin2.47%
Analyst Forecast
The average price target for Astrana Health is $41.57, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$41.57
Price Target Upside123.62% Upside
Analyst ConsensusStrong Buy
Analyst Count9
Revenue Growth Forecast56.69%
EPS Growth Forecast-15.92%